20 September 2022 in Electrochimica Acta
24 June 2021 in Measurement Science and Technology
Heat-resistant grids are important sensing elements for deformation measurements that use the sampling moiré method at high temperatures. To satisfy the fabrication demand for heat-resistant grids for the sampling moiré method, an etched-paint-film grid-fabrication technique using a laser-marking technique is proposed in this study. First, the important factors influencing the fabrication process are experimentally studied, and grids with a pitch of several hundred microns are successfully fabricated using the nickel-based superalloy GH4169. The experimental results at high temperatures show that the self-developed grids have high temperature resistance at up to 1050 °C. Furthermore, to minimize the thermal disturbance involved in sampling moiré measurements at high temperatures, an image grayscale-averaging technique is introduced to improve the measurement accuracy of the high-temperature deformation fields. As example applications, the elastic constants at 20 °C/650 °C and the thermal expansion coefficients (up to 1050 °C) of GH4169 are accurately measured using the sampling moiré method. The experimental results confirm the feasibility of the sampling moiré method and our self-developed heat-resistant grids for characterizing the thermomechanical parameters of materials. The technique for fabricating heat-resistant grids proposed in this work is suitable for various metal materials, and has good application potential for use in high-temperature deformation measurements.
1 December 2022 in Experimental Mechanics
28 October 2022 in Strain
30 January 2022 in Fundamental Research
HIV, the virus that causes acquired immunodeficiency syndrome (AIDS), can integrate into the genome of host cells and form latent reservoirs, making it undetectable by the immune system. Two studies published in Nature in January 2020 reported a ‘shock and kill’ strategy that aimed to activate the transcription of the latent reservoirs and render infected cells vulnerable to elimination by the immune system. Both study groups described interventions that were the most effective activation to date and were also reproducible. Nixon et al. used a drug called AZD5582 to activate the transcription of nuclear factor kappa B (NF-κB), a major inducer of HIV-1 gene expression [1]. McBrien et al. combined two immunological interventions by first depleting CD8 T cells (immune cells that reduce the level of viral transcription) followed by treatment with a drug called N-803, which activated HIV-1 transcription [2]. In addition to these advances, these two studies also demonstrated the conceptual and technical challenges of pharmacological latency reversal.①